ALK-positive and DUSP22-rearranged ALCLs have a better prognosis than triple-negative ALCL and TP63-rearranged ALCL, which have the worst outcome [2,3,5,6,7]. This evidence concerns the gene ALK and anaplastic large cell lymphoma.